Stifel Financial
ACHV icon

Stifel Financial’s Achieve Life Sciences ACHV Stock Holding History

Stifel Financial’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5
Closed -$4K – 2580
2017
Q2 		$4K Hold
5
– – ﹤0.01% 2558
2017
Q1 		$4K Hold
5
– – ﹤0.01% 2524
2016
Q4 		$4K Buy
+5
New +$4.94K ﹤0.01% 2459
2015
Q2 		– Sell
-5
Closed -$24K – 2352
2015
Q1 		$24K Hold
5
– – ﹤0.01% 2263
2014
Q4 		$24K Sell
5
-2
-29% -$9.78K ﹤0.01% 2256
2014
Q3 		$39K Hold
7
– – ﹤0.01% 2161
2014
Q2 		$54K Buy
7
+1
+17% +$12.3K ﹤0.01% 2137
2014
Q1 		$157K Buy
+6
New +$147K ﹤0.01% 1960

Other funds holding ACHV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Stifel Financial's ACHV Position: Q3 2017 in Review

Stifel Financial sold out of Achieve Life Sciences (ACHV) in Q3 2017, closing a stake of 5 shares — an estimated $4K sold.

Stifel Financial first reported a position in ACHV in Q1 2014 and held it in 8 quarters. The position peaked at $157K in Q1 2014. 15 funds tracked by Wall St. Rank hold ACHV as of Q3 2017.

  • Stifel Financial reported no remaining Achieve Life Sciences position as of Q3 2017 after selling out during the quarter.
  • Stifel Financial sold 5 Achieve Life Sciences shares in Q3 2017, an estimated $4K.
  • Stifel Financial first reported a position in Achieve Life Sciences in Q1 2014 and held it in 8 quarters.
  • Stifel Financial's Achieve Life Sciences position peaked at $157K in Q1 2014.
  • 15 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2017.

Based on Stifel Financial's 13F filing for Q3 2017, filed 13 Nov 2017.